Skip to main content

Meritxell Ventura Cots

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Meritxell Ventura Cots

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Research lines

Malaltia hepàtica relacionada amb l'alcohol

Malaltia avançada: hepatitis alcohòlica, cirrosis i malaltia hepàtica crònica per alcohol (cALD)

Salut pública

Insuficiència hepàtica aguda sobre crònica (ACLF)

IP: Meritxell Ventura Cots

Projects

Caracterización de las claves fisiopatológicas y fenotipos de la enfermedad del hígado graso metabólica con ingesta moderada de alcohol para identificar nuevas terapias (ReLiveR).

IP: Meritxell Ventura Cots
Collaborators: Immaculada Raurell Saborit, Juan Manuel Pericàs Pulido, Laura Puente Ramo, Ares Aurora Villagrasa Vilella, Juan Bañares Sanchez, Jesus Manuel Rivera Esteban
Funding agency: Instituto de Salud Carlos III
Funding: 183920
Reference: PI22/01770
Duration: 01/01/2023 - 31/12/2025

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: Beatriz Minguez Rosique, Sergi Colomer Castell, Elena Vargas Accarino, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Victor Manuel Vargas Blasco, Maria Buti Ferret, Montserrat Gomez Perez, Torrens Buscató, Maria Margarita, Judit Vico Romero, Josep Quer Sivila, Adriana Palom Agusti, Juan Manuel Pericàs Pulido, Maria Nieves Martell Pérez-Alcalde, Damir Garcia Cehic, Daniel Martinez Vazquez, Laura Puente Ramo, Isabel Campos Varela, María Bermúdez Ramos, Juan Ignacio Esteban Mur, Ester Palacio Gutierrez, Susana Anton Calvo, Monica Higuera Urbano, Meritxell Ventura Cots, Ares Aurora Villagrasa Vilella, Emma Bigas Alsina, Carolina Campos Martinez, Macarena Simon-Talero Horga, Jesus Manuel Rivera Esteban, David Tabernero Caellas, Mònica Pons Delgado, Marcella Salzano, Cesar Jimenez Hernandez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 30/06/2025

StopALD

IP: Meritxell Ventura Cots
Collaborators: Juan Manuel Pericàs Pulido, Sonia Carramiñana Mayor, Juan Bañares Sanchez
Funding agency: Ajuntament Barcelona
Funding: 119700
Reference: AJUNT.BCN/CIENCIA_INNOV/2022/VENTURA
Duration: 08/12/2022 - 07/06/2024

De la esteatohepatitis alcohólica temprana a la cirrosis descompensada: identificación de factores genéticos, epigenéticos y ambientales responsables de la aparición y progresión de la enfermedad hepática relacionada con el alcohol

IP: Meritxell Ventura Cots
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 180000
Reference: JR19/00015
Duration: 31/03/2020 - 30/03/2024

Related news

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

Related professionals

Joan Piñas Massó

Joan Piñas Massó

Biomedical Research in Cancer Stem Cells
Read more
Klimczak , Marta Kinga

Klimczak , Marta Kinga

Predoctoral researcher
Neurovascular Diseases
Read more
Francesc Casellas Jordá

Francesc Casellas Jordá

Physiology and Pathophysiology of the Digestive Tract
Read more
Franky Vargas, Enrique

Franky Vargas, Enrique

Research technician
Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.